CN1674875A - 抗微生物组合物及其应用方法 - Google Patents

抗微生物组合物及其应用方法 Download PDF

Info

Publication number
CN1674875A
CN1674875A CNA038189666A CN03818966A CN1674875A CN 1674875 A CN1674875 A CN 1674875A CN A038189666 A CNA038189666 A CN A038189666A CN 03818966 A CN03818966 A CN 03818966A CN 1674875 A CN1674875 A CN 1674875A
Authority
CN
China
Prior art keywords
turmeric
extract
composition
green tea
ginger
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA038189666A
Other languages
English (en)
Chinese (zh)
Inventor
理查德·A·罗森布卢姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prophase Labs Inc
Original Assignee
Quigley Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/024794 external-priority patent/WO2003013428A2/en
Priority claimed from US10/359,889 external-priority patent/US7396546B2/en
Application filed by Quigley Corp filed Critical Quigley Corp
Publication of CN1674875A publication Critical patent/CN1674875A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNA038189666A 2002-08-06 2003-07-24 抗微生物组合物及其应用方法 Pending CN1674875A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
USPCT/US02/24794 2002-08-06
PCT/US2002/024794 WO2003013428A2 (en) 2001-08-06 2002-08-06 Nutritional supplements and methods of using same
US10/359,889 US7396546B2 (en) 2001-08-06 2003-02-06 Anti-microbial compositions and methods of using same
US10/359,889 2003-02-06

Publications (1)

Publication Number Publication Date
CN1674875A true CN1674875A (zh) 2005-09-28

Family

ID=34549101

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA038189666A Pending CN1674875A (zh) 2002-08-06 2003-07-24 抗微生物组合物及其应用方法

Country Status (10)

Country Link
EP (1) EP1545470A4 (de)
JP (1) JP2005534699A (de)
CN (1) CN1674875A (de)
AU (1) AU2003256736B2 (de)
CA (1) CA2495447A1 (de)
HK (1) HK1082660A1 (de)
IL (1) IL166608A0 (de)
MX (1) MXPA05001051A (de)
NZ (1) NZ537821A (de)
WO (1) WO2004012655A2 (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102573870A (zh) * 2009-07-08 2012-07-11 韩国生命工学研究院 预防和治疗流感病毒感染的组合物和含姜黄提取物的用于抑制神经氨酸苷酶活性的组合物
CN101420966B (zh) * 2006-03-10 2013-07-17 纽崔西亚公司 不可消化的糖用于在出生后给予婴儿最佳开始的用途
CN108012530A (zh) * 2015-06-10 2018-05-08 拉曼·梅塔 用于治疗粘膜损伤的制剂

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166435B2 (en) 2001-08-06 2007-01-23 The Quigley Corporation Compositions and methods for reducing the transmissivity of illnesses
NZ526098A (en) * 2003-05-23 2005-10-28 Enzo Nutraceuticals Ltd Use of a plant extract containing flavonoids rich in proanthocyanidins for the prevention or treatment of migraine
JP2008505901A (ja) * 2004-07-07 2008-02-28 三井農林株式会社 耐久性のある殺生物剤および消毒剤
JP4788994B2 (ja) * 2005-01-26 2011-10-05 独立行政法人農業・食品産業技術総合研究機構 機能性飲食品
JP5032003B2 (ja) * 2005-06-15 2012-09-26 株式会社琉球バイオリソース開発 口腔粘膜用の鎮痛・抗炎症トローチ剤
FR2887748B1 (fr) * 2005-06-29 2009-09-04 Physcience Soc Par Actions Sim Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires.
FR2887749B1 (fr) * 2005-06-29 2009-09-04 Physcience Soc Par Actions Sim Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires
JP2009510003A (ja) * 2005-09-30 2009-03-12 ディーエスエム アイピー アセッツ ビー．ブイ． ポリフェノールを含有する新規の組成物
JP5207341B2 (ja) * 2006-10-26 2013-06-12 独立行政法人産業技術総合研究所 炎症性サイトカイン産生抑制剤
EP2091548A1 (de) * 2006-12-14 2009-08-26 The Quigley Corporation Verfahren zur behandlung und verringerung der inzidenz von newcastle-krankheit
MX2009006396A (es) * 2006-12-14 2009-06-26 The Quigley Corp Composiciones y metodos para tratar bronquitis infecciosa.
KR101121615B1 (ko) 2009-09-14 2012-02-28 주식회사 바이오에프디엔씨 항균용 세정제 조성물
KR100962334B1 (ko) * 2009-10-19 2010-06-10 주식회사 중앙백신연구소 울금으로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제
CA2778414C (en) 2009-10-22 2017-07-04 Biopharmacopae Design International Inc. Herbal composition comprising ginger and goldenrod for the treatment of cold and flu
ITMI20111259A1 (it) * 2011-07-06 2013-01-07 Eye Tech Srl Composizione orosolubile a rapida disgregazione contenente derivati di curcumina
JP2013100253A (ja) * 2011-11-09 2013-05-23 Shigeru Abe ショウガ成分を含む抗カンジダ活性組成物
US20140294990A1 (en) * 2013-03-27 2014-10-02 Timothy P. O'Connor Throat gargle tablet and method of use thereof
JP2019011279A (ja) * 2017-06-30 2019-01-24 小林製薬株式会社 下痢抑制剤
JP2023063212A (ja) * 2021-10-22 2023-05-09 花王株式会社 ウイルス不活化剤
CN120093719A (zh) * 2023-12-06 2025-06-06 北京远大九和药业有限公司 一种药物组合物及其用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6032705A (ja) * 1983-08-02 1985-02-19 Shiraimatsu Shinyaku Kk 抗微生物剤
JPH02276562A (ja) * 1989-04-19 1990-11-13 Mitsui Norin Kk 抗菌剤
JPH0319670A (ja) * 1989-06-17 1991-01-28 Chieko Shiroi ウコン混合の穀物及びその加工食品
CN1060012A (zh) * 1991-09-20 1992-04-08 沈阳市铁西区科发医药饮料技术服务部 一种口香糖的制作方法
CN1072823A (zh) * 1992-06-13 1993-06-09 文士开 果酶茶的配制方法
JP2540719B2 (ja) * 1993-10-21 1996-10-09 有限会社ビオールケミカル 茶の葉
CN1116068A (zh) * 1994-01-25 1996-02-07 刘俊松 天然乳化果茶主剂的制备方法
JPH10130161A (ja) * 1996-09-06 1998-05-19 Otsuka Pharmaceut Co Ltd ヘリコバクター・ピロリに対する組成物
JPH10279432A (ja) * 1997-04-01 1998-10-20 Nisshin Oil Mills Ltd:The 組成物
JPH11302121A (ja) * 1998-04-16 1999-11-02 Fuudeiamu Tokunaga:Kk 緑茶カテキンを用いた抗菌剤
JP2000212094A (ja) * 1998-11-18 2000-08-02 Takeda Chem Ind Ltd 口腔用製剤
JP2000157209A (ja) * 1998-11-27 2000-06-13 Kagetoshi Kawauchi 振り掛け健康食品
US6264995B1 (en) * 1999-10-19 2001-07-24 Thomas Newmark Herbal composition for reducing inflammation and methods of using same
US6261607B1 (en) * 1999-10-19 2001-07-17 Thomas Newmark Composition for promoting prostate health containing selenium and herbal extracts
US6596313B2 (en) * 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101420966B (zh) * 2006-03-10 2013-07-17 纽崔西亚公司 不可消化的糖用于在出生后给予婴儿最佳开始的用途
CN102573870A (zh) * 2009-07-08 2012-07-11 韩国生命工学研究院 预防和治疗流感病毒感染的组合物和含姜黄提取物的用于抑制神经氨酸苷酶活性的组合物
US8545903B2 (en) 2009-07-08 2013-10-01 Korea Research Institute Of Bioscience And Biotechnology Composition for the prevention and treatment of influenza virus infection and composition for suppressing neuraminidase activity comprising turmeric extract
CN102573870B (zh) * 2009-07-08 2015-06-03 韩国生命工学研究院 预防和治疗流感病毒感染的组合物和含姜黄提取物的用于抑制神经氨酸苷酶活性的组合物
CN108012530A (zh) * 2015-06-10 2018-05-08 拉曼·梅塔 用于治疗粘膜损伤的制剂
CN108012530B (zh) * 2015-06-10 2021-07-02 拉曼·梅塔 用于治疗粘膜损伤的制剂

Also Published As

Publication number Publication date
EP1545470A4 (de) 2009-07-01
WO2004012655A3 (en) 2004-09-16
IL166608A0 (en) 2006-01-15
AU2003256736A1 (en) 2004-02-23
NZ537821A (en) 2007-05-31
HK1082660A1 (zh) 2006-06-16
JP2005534699A (ja) 2005-11-17
EP1545470A2 (de) 2005-06-29
CA2495447A1 (en) 2004-02-12
MXPA05001051A (es) 2005-04-08
WO2004012655A2 (en) 2004-02-12
AU2003256736B2 (en) 2009-09-10

Similar Documents

Publication Publication Date Title
US7396546B2 (en) Anti-microbial compositions and methods of using same
CN100469355C (zh) 营养增补剂及其使用方法
US20030185918A1 (en) Nutritional supplements and methods of using same
AU2003256736B2 (en) Anti-microbial compositions and methods of using same
AU2002332464A1 (en) Nutritional supplements and methods of using same
Abd El-Hack et al. Nutritional, healthical and therapeutic efficacy of black cumin (Nigella sativa) in animals, poultry and humans
CN101111608A (zh) 降低疾病传染性的组合物和方法
US7507425B2 (en) Method for the treatment of cachexia
CN1925863A (zh) 用于治疗sars的黄芩属提取物
CN101557815A (zh) 用于治疗传染性支气管炎的组合物和方法
US7175987B2 (en) Compositions and methods for treatment of herpes
Akbaş et al. COVID-19 and Phytotherapy
CN101557816A (zh) 治疗和降低新城疫发病率的方法
CN1277555A (zh) 用于改善哺乳动物智力机能的组合物
CN1254266C (zh) 感冒胶囊及其制备方法
CN1460492A (zh) 治疗急慢性鼻炎的中药制剂及其生产方法
KR20050033069A (ko) 항생 조성물 및 그 사용 방법
FR3096892A1 (fr) Composition anti-inflammatoire comprenant des constituants d’origine végétale
Essien Determination of the effect of co-administration of Andrographis paniculata leaves and Zingiber officinale rhizoids on serum liver enzymes in normal Albino wistar rats
RATHOUR et al. Review on Syzygium cumini Linn: A promising ethnopharmacological plant.
ZA200500517B (en) Anti-microbial compositions and methods of using same.
JPWO2004039388A1 (ja) α−グルコシダーゼ阻害剤
officinarum Hance Alpinia officinarum

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20050928